972646941	972646941	CD	B-NP	O
|	|	NN	I-NP	O
PH	PH	NN	I-NP	O
|	|	NN	I-NP	O
11042044	11042044	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0528994	0528994	CD	B-NP	O
|	|	CC	I-NP	O
8/10/2003	8/10/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
colonic	colonic	JJ	I-NP	O
microperforation	microperforation	NN	I-NP	O
,	,	,	O	O
afib	afib	JJ	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/17/2003	8/17/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/17/2003	1/17/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
GVERRERO	GVERRERO	NN	I-NP	O
,	,	,	O	O
STAN	STAN	NNP	B-NP	O
O	O	NNP	I-NP	O
846-18-77-7	846-18-77-7	CD	I-NP	O
Irv	Irv	NNP	I-NP	O
Lu	Lu	NNP	I-NP	O
Spo	Spo	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
3/5/03	3/5/03	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KERSON	KERSON	NNP	B-NP	O
,	,	,	O	O
RODNEY	RODNEY	NNP	B-NP	O
S	S	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
FESO4	FESO4	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/3	8/3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
FOLATE	FOLATE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FOLIC	FOLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
SYNTHROID	SYNTHROID	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MCG	MCG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
PREDNISONE	PREDNISONE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
ZOCOR	ZOCOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/22/03	9/22/03	CD	B-NP	O
by	by	IN	B-PP	O
LIU	LIU	NNP	B-NP	O
,	,	,	O	O
HERMAN	HERMAN	NNP	B-NP	O
ANTONIO	ANTONIO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
NEORAL	NEORAL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
08325601	08325601	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
CYCLOSPORINE	CYCLOSPORINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
NEORAL	NEORAL	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
CYCLOSPORINE	CYCLOSPORINE	NN	I-NP	O
MICRO	MICRO	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NEORAL	NEORAL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/22/03	9/22/03	CD	B-NP	O
by	by	IN	B-PP	O
ELVEY	ELVEY	NNP	B-NP	O
,	,	,	O	O
EDMUND	EDMUND	NNP	B-NP	O
LENNY	LENNY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LOSARTAN	LOSARTAN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
83393813	83393813	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
&	&	CC	I-NP	O
LOSARTAN	LOSARTAN	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/22/03	9/22/03	CD	B-NP	O
by	by	IN	B-PP	O
LYNADY	LYNADY	NNP	B-NP	O
,	,	,	O	O
LAMONT	LAMONT	NNP	B-NP	O
LORENZO	LORENZO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
CYCLOSPORINE	CYCLOSPORINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
LOSARTAN	LOSARTAN	NNP	B-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/22/03	9/22/03	CD	B-NP	O
by	by	IN	B-PP	O
CONOLEY	CONOLEY	NNP	B-NP	O
,	,	,	O	O
KELLEY	KELLEY	NNP	B-NP	O
OTHA	OTHA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CYCLOSPORINE	CYCLOSPORINE	NNP	B-NP	O
&	&	CC	I-NP	O
LOSARTAN	LOSARTAN	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
25	25	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
400	400	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
400	400	CD	B-NP	O
bid	bid	NN	I-NP	O
x	x	SYM	B-NP	O
6	6	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
400	400	CD	B-NP	O
qd	qd	NN	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
200	200	CD	B-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/5/03	3/5/03	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ECASA	ECASA	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/25	8/25	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
start	start	VB	I-VP	O
on	on	IN	B-PP	O
4/21	4/21	CD	B-NP	O
.	.	.	O	O

FLAGYL	FLAGYL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
METRONIDAZOLE	METRONIDAZOLE	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
2	2	CD	I-NP	I-protein
Days	Day	NNPS	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	B-protein
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
2	2	CD	I-NP	I-protein
Days	Day	NNPS	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/25	8/25	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/5/03	3/5/03	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Schultheiss	Schultheiss	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cardiology	cardiology	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
6/7/03	6/7/03	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Gastroenterology	Gastroenterology	NNP	B-NP	O
-	-	HYPH	O	O
Dr.	Dr.	NNP	B-NP	O
Degener	Degener	NNP	I-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Iv	Iv	NN	B-NP	O
contrast	contrast	NN	I-NP	O
dyes	dye	NNS	I-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Erythromycins	Erythromycins	NNP	B-NP	O
,	,	,	O	O
Morphine	Morphine	NNP	B-NP	O
,	,	,	O	O
Demerol	Demerol	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Aspiration	Aspiration	NN	B-NP	O
PNA	PNA	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
colonic	colonic	JJ	I-NP	O
microperforation	microperforation	NN	I-NP	O
,	,	,	O	O
afib	afib	JJ	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hodgkin	hodgkin	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Hodgkins	Hodgkins	NNP	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
renal	renal	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
kidney	kidney	NN	I-NP	O
transplant	transplant	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
appy	appy	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
h/o	h/o	NN	I-NP	O
A	A	NN	I-NP	O
fib	fib	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
polyarteritis	polyarteritis	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Colonoscopy	Colonoscopy	NN	B-NP	O
under	under	IN	B-PP	O
general	general	JJ	B-NP	O
anesthesia	anesthesia	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
74	74	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
in	in	IN	B-PP	O
remission	remission	NN	B-NP	O
from	from	IN	B-PP	O
Hodgkin	Hodgkin	NN	B-NP	O
's	's	POS	B-NP	O
Lymphoma	Lymphoma	NN	I-NP	O
and	and	CC	I-NP	O
s/p	s/p	NN	I-NP	B-protein
renal	renal	JJ	I-NP	I-protein
transplant	transplant	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
1/20	1/20	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
who	who	WP	B-NP	O
p/w	p/w	VBP	B-VP	O
hypoxia	hypoxia	NN	B-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
grade	grade	NN	I-NP	O
fever	fever	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
colonoscopy	colonoscopy	NN	B-NP	O
under	under	IN	B-PP	O
general	general	JJ	B-NP	O
anesthesia	anesthesia	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
PET	PET	NN	B-NP	O
scan	scan	NN	I-NP	O
on	on	IN	B-PP	O
4/3	4/3	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
uptake	uptake	NN	B-NP	O
in	in	IN	B-PP	O
asc	asc	NN	B-NP	O
colon	colon	NN	I-NP	O
and	and	CC	O	O
hep	hep	NN	B-NP	O
flexure	flexure	NN	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
malignancy	malignancy	NN	B-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
showed	show	VBD	B-VP	O
1.6	1.6	CD	B-NP	O
les	le	NNS	I-NP	O
in	in	IN	B-PP	O
desc	desc	NN	B-NP	O
colon	colon	NN	I-NP	O
and	and	CC	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
under	under	IN	B-PP	O
GA	GA	NN	B-NP	B-protein
performed	perform	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
difficulty	difficulty	NN	B-NP	O
of	of	IN	B-PP	O
going	go	VBG	B-VP	O
beyond	beyond	IN	B-PP	O
hep	hep	NN	B-NP	O
flexure	flexure	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
hypoxia	hypoxia	NN	B-NP	O
to	to	TO	B-PP	O
80s	80s	CD	B-NP	O
when	when	WRB	B-ADVP	O
awakening	awaken	VBG	B-VP	O
from	from	IN	B-PP	O
anesthesia	anesthesia	NN	B-NP	O
.	.	.	O	O

Temp	Temp	NN	B-NP	O
to	to	TO	B-PP	O
101.1	101.1	CD	B-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
?	?	.	O	O

LLL	LLL	NN	B-NP	O
opacity	opacity	NN	I-NP	O
.	.	.	O	O

Thought	Think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
likely	likely	JJ	B-NP	O
Pneumonitis	Pneumonitis	NN	I-NP	O
vs.	vs.	IN	B-PP	O
asp	asp	NN	B-NP	O
PNA	PNA	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
Pacu	Pacu	NNP	B-NP	O
Pt	Pt	NNP	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
TWIs	TWI	NNS	B-NP	O
and	and	CC	O	O
?	?	.	O	O

BBB	BBB	NN	B-NP	O
assoc	assoc	NN	I-NP	O
with	with	IN	B-PP	O
HR70s-80s	HR70s-80	NNS	B-NP	B-protein
.	.	.	O	O

EKGs	EKG	NNS	B-NP	B-protein
resolved	resolve	VBD	B-VP	O
when	when	WRB	B-ADVP	O
rate	rate	NN	B-NP	O
in	in	IN	B-PP	O
60s	60	NNS	B-NP	O
.	.	.	O	O

Physical	Physical	NNP	B-NP	O
Exam	Exam	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
AOOx3	AOOx3	NN	B-NP	O
woman	woman	NN	I-NP	O
in	in	IN	B-PP	O
NAD	NAD	NN	B-NP	O
.	.	.	O	O

PERRL	PERRL	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
2/6	2/6	CD	B-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
RUSB	RUSB	NNP	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
crackles	crackle	NNS	B-NP	O
at	at	IN	B-PP	O
LL	LL	NN	B-NP	B-protein
base	base	NN	I-NP	I-protein
to	to	TO	B-PP	O
mid	mid	JJ	B-NP	O
lung	lung	NN	I-NP	O
field	field	NN	I-NP	O
.	.	.	O	O

Abd	Abd	NN	B-NP	O
exam	exam	NN	I-NP	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
rebound	rebound	NN	B-NP	O
and	and	CC	I-NP	O
invol	invol	NN	I-NP	O
guarding	guarding	NN	I-NP	O
.	.	.	O	O

Tenderness	Tenderness	NN	B-NP	O
in	in	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	O
and	and	CC	I-NP	O
suprapubic	suprapubic	JJ	I-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
BS	BS	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
hepatomegaly	hepatomegaly	NN	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
HCt	HCt	NN	B-NP	B-protein
24	24	CD	I-NP	I-protein
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
1.9	1.9	CD	I-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
****************	****************	SYM	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Pulm-On	Pulm-On	JJ	B-NP	O
floor	floor	NN	I-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
oxygenation	oxygenation	NN	I-NP	O
improved	improve	VBD	B-VP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
to	to	TO	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
Likely	Likely	RB	I-NP	O
aspiration	aspiration	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
final	final	JJ	B-NP	O
read	read	NN	I-NP	O
on	on	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
shows	show	VBZ	B-VP	O
no	no	DT	B-NP	O
infiltrate/opacity	infiltrate/opacity	NN	I-NP	O
.	.	.	O	O

Levo/Flagyl	Levo/Flagyl	NN	B-NP	O
given	give	VBN	B-VP	O
empirically	empirically	RB	B-ADVP	O
x	x	NN	B-NP	O
5days	5day	NNS	I-NP	O
though	though	IN	B-SBAR	O
she	she	PRP	B-NP	O
remained	remain	VBD	B-VP	O
afeb	afeb	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CV-Pt	CV-Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
h/o	h/o	NN	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	O
stent	stent	NN	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
AS	AS	NN	I-NP	O
.	.	.	O	O

Low	Low	JJ	B-NP	O
Hct	Hct	NN	I-NP	O
and	and	CC	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
hypoxic	hypoxic	JJ	I-NP	O
episode	episode	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

Transfused	Transfuse	VBN	B-NP	O
2u	2u	NN	I-NP	O
PRBCs	PRBC	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
4/23	4/23	CD	B-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
Afib	Afib	NN	B-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
to	to	TO	B-PP	O
130s	130	NNS	B-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
arm	arm	NN	I-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
anginal	anginal	JJ	I-NP	O
equivalent	equivalent	NN	I-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
with	with	IN	B-PP	O
rate	rate	NN	B-NP	O
related	related	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
V5-6	V5-6	NN	I-NP	O
,	,	,	O	O
L.	L.	NNP	B-NP	O
+	+	SYM	B-VP	O
Minimal	Minimal	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
to	to	TO	B-PP	O
0.19	0.19	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
subseq	subseq	NN	B-NP	O
downtrended	downtrende	VBD	B-VP	O
with	with	IN	B-PP	O
nl	nl	NN	B-NP	B-protein
CK	CK	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
init	init	NN	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
lopressor	lopressor	NN	B-NP	O
5mg	5mg	NN	I-NP	O
IV	IV	CD	I-NP	O
but	but	CC	O	O
had	have	VBD	B-VP	O
hypotension	hypotension	NN	B-NP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
's	's	POS	B-NP	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
quickly	quickly	RB	B-ADVP	O
with	with	IN	B-PP	O
IVF	IVF	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
eventually	eventually	RB	B-ADVP	O
rate	rate	NN	B-NP	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
dilt	dilt	JJ	B-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Cards	Card	NNS	B-NP	O
c/s	c/	NNS	I-NP	O
'd	'd	VBD	B-VP	O
and	and	CC	I-VP	O
recommended	recommend	VBD	I-VP	O
amio	amio	NN	B-NP	O
load	load	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
PFT	PFT	NNP	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
LFT	LFT	NNP	B-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
TFT	TFT	NN	B-NP	O
's	's	POS	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

Plan	Plan	NN	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Lenberg	Lenberg	NNP	I-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
anticoagulation	anticoagulation	NN	B-NP	O
for	for	IN	B-PP	O
PAF	PAF	NN	B-NP	B-protein
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
2nd	2nd	JJ	I-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
ecasa	ecasa	NN	B-NP	O
5d	5d	CD	I-NP	O
p	p	NN	I-NP	O
colonosco	colonosco	NN	I-NP	O
py	py	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

GI-Pt	GI-Pt	NN	B-NP	O
had	have	VBD	B-VP	O
abd	abd	NN	B-NP	O
exam	exam	NN	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
focal	focal	JJ	B-NP	O
peritoneal	peritoneal	JJ	I-NP	O
irritation	irritation	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
microperforation	microperforation	NN	I-NP	O
during	during	IN	B-PP	O
colonoscopy	colonoscopy	NN	B-NP	O
as	as	IN	B-SBAR	O
CT	CT	NN	B-NP	O
showed	show	VBD	B-VP	O
fluid	fluid	NN	B-NP	O
in	in	IN	B-PP	O
pelvis	pelvis	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
Hct	Hct	NN	B-NP	O
drop	drop	NN	I-NP	O
requiring	require	VBG	B-VP	O
2U	2U	NN	B-NP	O
pRBC	pRBC	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
exam	exam	NN	I-NP	O
improved	improve	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
tolerating	tolerate	VBG	I-VP	O
PO	PO	NN	B-NP	B-protein
well	well	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
afeb	afeb	RB	I-VP	O
and	and	CC	I-VP	O
well	well	RB	I-VP	O
appearing	appear	VBG	I-VP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

Plan	Plan	NN	B-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
5d	5d	CD	B-NP	O
abx	abx	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
per	per	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Thorburn	Thorburn	NNP	I-NP	O
her	her	PRP$	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
was	be	VBD	B-VP	O
complex	complex	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
polypectomy	polypectomy	NN	B-NP	O
of	of	IN	B-PP	O
2.5	2.5	CD	B-NP	O
cm	cm	NN	I-NP	O
polyp	polyp	NN	I-NP	O
.	.	.	O	O

Path	Path	NN	B-NP	O
is	be	VBZ	B-VP	O
pending	pende	VBG	B-ADJP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
+	+	SYM	B-NP	O
for	for	IN	B-PP	O
cancer	cancer	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
looked	look	VBD	B-VP	O
``	``	``	O	O
clean	clean	JJ	B-ADJP	O
''	''	''	O	O
,	,	,	O	O
so	so	RB	B-ADVP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
feasible	feasible	JJ	B-ADJP	O
to	to	TO	B-VP	O
re-scope	re-scope	VB	I-VP	O
her	her	PRP	B-NP	O
for	for	IN	B-PP	O
surveillance	surveillance	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
later	later	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
GI	GI	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Hct	Hct	NN	I-NP	B-protein
after	after	IN	B-SBAR	O
colonoscopy	colonoscopy	NN	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
24	24	CD	B-NP	O
-LRB-	-LRB-	SYM	O	O
baseline	baseline	NN	B-NP	O
30	30	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
post-transfusion	post-transfusion	JJ	B-NP	O
HCt	HCt	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

s/p	s/p	NN	B-NP	O
Renal	Renal	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
.	.	.	O	O

Continuing	Continue	VBG	B-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
HAJDUKIEWICZ	HAJDUKIEWICZ	NN	B-NP	O
,	,	,	O	O
CLIFFORD	CLIFFORD	NNP	B-NP	O
NICHOLAS	NICHOLAS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HE572	HE572	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/5/03	3/5/03	CD	I-NP	O
@	@	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
24	24	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

